Ohio Police Shoot and Kill Unarmed Black Man

Sep.01.2022
Ohio Police Shoot and Kill Unarmed Black Man
Ohio cop fatally shoots an unarmed 20-year-old black man holding an e-cigarette, mistaken for a gun, sparking investigations.

A police officer in Ohio fatally shot a 20-year-old black male who was holding an electronic cigarette and raised his hands. The police thought it was a gun.


At a press conference held several hours later, Police Chief Elaine Bryant played body camera footage. The video showed police arriving at an apartment on Sullivan Avenue around 2:30 am to serve an arrest warrant for Lewis, who was wanted for assault. Police waited outside the front door for about 10 minutes before two men emerged and were detained, but there was no sign of Lewis initially. Police then sent in a barking K-9 dog and followed it into the home. Moments later, K-9 Officer Ricky Anderson opened the bedroom door and found Lewis in bed, where he was immediately shot and killed.


According to Bryant, a frame-by-frame review of the video shows that Lewis appeared to have "something" in his hand as he raised his hands when police opened the door and pointed their guns at him.


Kobe stated that no firearms were found on the scene, but an electronic vaping device was discovered on the bed.


According to the Columbus Dispatch, after being shot, the dying Lewis was ordered to "get up" from his bed, then handcuffed and removed from the apartment. After receiving CPR on scene, Lewis was taken to OhioHealth Grant Medical Center where he died within an hour. The chief did not comment on whether authorities believed Lewis had a weapon in his possession, a question that is expected to be resolved by the investigation launched by the Ohio Bureau of Criminal Investigation.


Kobe expressed sympathy and sadness for Donovan Lewis' mother upon his passing. He also expressed sorrow for the community, but stated that they will allow the investigation to proceed. As the newly hired official, he emphasized the city's commitment to holding any officials responsible for any wrongdoing, but stressed that a national investigation must be conducted first.


Disclaimer: 1. The content of this article is compiled from third-party information, and is intended solely for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the accuracy and authenticity of the content. The compilation of this article is for industry exchange and research only. 3. Due to limitations in the level of compilation, the content may differ from the original. Please refer to the original article for accuracy. 4. 2FIRSTS fully aligns with the Chinese government regarding any statements and positions related to domestic, Hong Kong, Macao, Taiwan, and foreign matters. 5. The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
According to Bloomberg, Dubai-based hookah brand owner Advanced Inhalation Rituals (AIR) plans to go public on Nasdaq in the first half of 2026 through a merger with a Cantor Fitzgerald-backed SPAC. The deal values the combined company at USD 1.75 billion under the ticker “AIIR.”
Nov.11
China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
China Customs seized 265,140 oral nicotine pouches, including “ZYN”-branded and unbranded products, over suspected IP infringement and breaches of tobacco export rules.
Oct.10 by 2FIRSTS.ai
Product | AutoFresh Lock + Transparent Tank: SKE’s MEMERS VAPE Launches New Device
Product | AutoFresh Lock + Transparent Tank: SKE’s MEMERS VAPE Launches New Device
SKE-owned MEMERS has listed the disposable FRESA 40K on its website, featuring a transparent e-liquid chamber and a battery level display, with a claimed up to 40,000 puffs. The device uses Fresh Lock+ auto oil-lock to isolate e-liquid from the coil; brand materials cite two trigger timings—6 seconds after each puff or after 5 minutes of inactivity. It includes a 900mAh rechargeable battery, Type-C charging, and comes in 10 flavors.
Nov.05 by 2FIRSTS.ai
Portugal to Tax Nicotine Pouches from 2026 at €0.065 per Gram
Portugal to Tax Nicotine Pouches from 2026 at €0.065 per Gram
Portugal’s 2026 State Budget adds nicotine pouches to the IEC by inserting Article 104-D into the Excise Code’s tobacco chapter. A specific duty of €0.065/g applies from 2026, with rounding to whole grams. The Budget also defines pouches (natural nicotine, up to 12 mg, tobacco-free, oral mucosal absorption). Lusa projects €1.676B in tobacco excise for 2026; combined levies near €1.993B.
Oct.30 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%
BAT Korea Announces Fall Promotion for glo™ hyper Series, Price Reductions up to 40%
BAT Rothmans introduces "glo hyper" series promotion in South Korea, with "glo hyper pro" for $20 and "glo hyper" for $14.
Oct.15 by 2FIRSTS.ai